Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe: A TBNET consensus statement

C. Lange, I. Abubakar, J.-W.C. Alffenaar, G. Bothamley, J.A. Caminero, A.C.C. Carvalho, K.-C. Chang, L. Codecasa, A. Correia, V. Crudu, P. Davies, M. Dedicoat, F. Drobniewski, R. Duarte, C. Ehlers, C. Erkens, D. Goletti, G. Günther, E. Ibraim, B. KampmannL. Kuksa, W. De Lange, F. Van Leth, J. Van Lunzen, A. Matteelli, D. Menzies, I. Monedero, E. Richter, S. Rüsch-Gerdes, A. Sandgren, A. Scardigli, A. Skrahina, E. Tortoli, G. Volchenkov, D. Wagner, M.J. Van Der Werf, B. Williams, W.-W. Yew, J.-P. Zellweger, D.M. Cirillo

Research output: Contribution to JournalArticleAcademicpeer-review


The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific advances in MDR/XDR-TB care, decisions for the management of patients with MDR/XDR-TB and their contacts often rely on expert opinions, rather than on clinical evidence. This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking. © ERS 2014.
Original languageEnglish
Pages (from-to)23-63
JournalEuropean Respiratory Journal
Issue number1
Publication statusPublished - 1 Jul 2014
Externally publishedYes


Dive into the research topics of 'Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe: A TBNET consensus statement'. Together they form a unique fingerprint.

Cite this